1. © Copyright 2002 Frost & Sullivan. All Rights Reserved. U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators "A number of large clinical trials have recently demonstrated the benefits associated with improving the lipid profile. Because most physicians base prescription decisions on the results of large clinical trials, doctors who are aware of statins are gaining confidence in their use." Pharmaceuticals Analyst Team Frost & Sullivan

2. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging applications in the lipid regulators market Market sizing and competitive analysis Market forecasts and opportunity analysis Quarterly assessments End user analysis within each report Key Features

3. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We Offer

4. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of companies Determine which participants will outperform the competition Assess attractiveness of investing in the market Who Will Benefit?

5. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Abbott Laboratories Alpharma, Inc./Purepac Pharmaceutical Co. Apotex Corp. Astra Zeneca Pharmaceuticals LP Avant Immunotherapeutics, Inc. Aventis Pharmaceuticals, Inc. Barr Laboratories Bayer Corp. Bristol Myers Squibb Co. CV Therapeutics, Inc. Digital Gene Technologies, Inc. Eli Lilly and Co. Esperion Therapeutics, Inc. Ethypharm SA Geltex Pharmaceuticals, Inc. Genpharm, Inc. GlaxoSmithkline Impax Labs Incyte Genomics, Inc. KOS Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Mylan Pharmaceuticals Novartis Pharmaceuticals Corp. Par Pharmaceuticals, Inc. Key Market Participants

6. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information